Neogen Corp Files 8-K: Director, Officer, and Compensation Updates
Ticker: NEOG · Form: 8-K · Filed: Aug 14, 2025 · CIK: 711377
| Field | Detail |
|---|---|
| Company | Neogen Corp (NEOG) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.16, $750 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, filing-update
Related Tickers: NEOG
TL;DR
NEOG filed an 8-K covering director changes and exec comp. Details to follow.
AI Summary
On August 14, 2025, Neogen Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also includes information on other events and financial statements, though specific details on dollar amounts or new appointments were not immediately available in the provided text.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate governance and compensation matters, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- NEOGEN CORP (company) — Registrant
- August 14, 2025 (date) — Date of earliest event reported
- Michigan (location) — State of Incorporation
- Lansing (location) — City of Principal Executive Offices
FAQ
What specific changes were made to Neogen Corporation's board of directors?
The filing indicates that there were changes related to the 'Departure of Directors or Certain Officers' and 'Election of Directors', but the specific names and details of these changes are not provided in the excerpt.
What are the key details regarding the compensatory arrangements of certain officers mentioned in the filing?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item of disclosure, but the specific details of these arrangements are not included in the provided text.
What is the SIC code for Neogen Corporation?
The Standard Industrial Classification (SIC) code for Neogen Corporation is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
When is Neogen Corporation's fiscal year end?
Neogen Corporation's fiscal year ends on May 31.
What is the filing date of this 8-K report?
The 8-K report was filed on August 14, 2025.
Filing Stats: 729 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2025-08-14 16:18:12
Key Financial Figures
- $0.16 — nge on which registered Common Stock, $0.16 par value per share NEOG Nasdaq Glo
- $750 million — nc., where he built the business into a $750 million global portfolio and launched the first
Filing Documents
- neog-20250814.htm (8-K) — 50KB
- neog-ex99_1.htm (EX-99.1) — 7KB
- 0000950170-25-108900.txt ( ) — 164KB
- neog-20250814.xsd (EX-101.SCH) — 24KB
- neog-20250814_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On August 14, 2025, Neogen issued a press release announcing the retirement of a current board member and appointment of a new board member. A copy of this press release is furnished as Exhibit 99.1
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release dated August 14, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEOGEN CORPORATION Date: August 14, 2025 By: /s/ Amy M. Rocklin Name: Amy M. Rocklin Title: Chief Legal & Compliance Officer, Corporate Secretary